http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108103196-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_aa0a365668b8e763faf4d1dcad0e7b83 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_dee3ba4b73b64faf4a6116d71f1de931 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-118 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-154 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6886 |
| filingDate | 2018-02-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_51da94a8270970bb047aa17c47477961 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_00815cf43eba28538777717499269911 |
| publicationDate | 2018-06-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-108103196-A |
| titleOfInvention | It is a kind of to be used to detect gene marker of the cancer of the esophagus and application thereof and detection method |
| abstract | The invention discloses a kind of for detecting gene marker of the cancer of the esophagus and application thereof and detection method, gene marker includes one or more from the following gene：Phospholipid inositol phospho-esterase c X domains include albumen 3, sulfatase 1, F Box and full asphalt mixture albumen 7, Tolloid albuminoids 1, the single-stranded action protein matter 3 of RNA combination templates, ADAMTS albuminoids 1, phosphodiesterase 10 A, LIM domains ligase 2,3 subtribe of gamma amino butyric acid A receptor albumen gamma and 155 family protein member A of sequence similarity.The purposes of the gene marker is to be used as the detection cancer of the esophagus.The present invention can use more extensive DNA sample source；Safety is noninvasive, also high to the detection acceptance even if Silent cerebral infarction；Accuracy is high, there is higher sensitivity and specificity to the early stage cancer of the esophagus, and easy to operate, user experience is good, easily carries out the dynamic monitoring of recurrence of Esophageal Carcinoma and transfer. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112180088-B http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112180088-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019149093-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113406328-B http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113406328-A |
| priorityDate | 2018-02-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 82.